Fatemi, S.H.; Otte, E.D.; Folsom, T.D.; Eschenlauer, A.C.; Roper, R.J.; Aman, J.W.; Thuras, P.D.
Early Chronic Fluoxetine Treatment of Ts65Dn Mice Rescues Synaptic Vesicular Deficits and Prevents Aberrant Proteomic Alterations. Genes 2024, 15, 452.
https://doi.org/10.3390/genes15040452
AMA Style
Fatemi SH, Otte ED, Folsom TD, Eschenlauer AC, Roper RJ, Aman JW, Thuras PD.
Early Chronic Fluoxetine Treatment of Ts65Dn Mice Rescues Synaptic Vesicular Deficits and Prevents Aberrant Proteomic Alterations. Genes. 2024; 15(4):452.
https://doi.org/10.3390/genes15040452
Chicago/Turabian Style
Fatemi, S. Hossein, Elysabeth D. Otte, Timothy D. Folsom, Arthur C. Eschenlauer, Randall J. Roper, Justin W. Aman, and Paul D. Thuras.
2024. "Early Chronic Fluoxetine Treatment of Ts65Dn Mice Rescues Synaptic Vesicular Deficits and Prevents Aberrant Proteomic Alterations" Genes 15, no. 4: 452.
https://doi.org/10.3390/genes15040452
APA Style
Fatemi, S. H., Otte, E. D., Folsom, T. D., Eschenlauer, A. C., Roper, R. J., Aman, J. W., & Thuras, P. D.
(2024). Early Chronic Fluoxetine Treatment of Ts65Dn Mice Rescues Synaptic Vesicular Deficits and Prevents Aberrant Proteomic Alterations. Genes, 15(4), 452.
https://doi.org/10.3390/genes15040452
